About EUSA Pharma

Sponsor retains sole responsibility for content

Founded in March 2015, EUSA Pharma is a profitable commercial-stage specialty pharmaceutical company with global reach from its headquarters in the UK and its commercial operations across Europe and the USA. EUSA Pharma has a portfolio of approved Oncology therapeutic and supportive care products including: FOTIVDA® (tivozanib) for the treatment of advanced RCC, QARZIBA® (dinutuximab beta) for the...

Founded in March 2015, EUSA Pharma is a profitable commercial-stage specialty pharmaceutical company with global reach from its headquarters in the UK and its commercial operations across Europe and the USA. EUSA Pharma has a portfolio of approved Oncology therapeutic and supportive care products including: FOTIVDA® (tivozanib) for the treatment of advanced RCC, QARZIBA® (dinutuximab beta) for the treatment of HR Neuroblastoma, Caphosol® and Caphosol® DISPERSIBLE, for the treatment and prevention of Oral Mucositis.

Contact EUSA Pharma

Phone Number
+44 (0)330 5001140

More About EUSA Pharma

Therapeutic Areas
  • Oncology
Technologies
  • Antimicrobial
  • Biologics
  • Diagnostics
  • Regenerative medicine
  • Surgery
Company Type
  • Pharmaceutical
State of Ownership
  • Private
Sponsorship Group
  • Partner
  • Networker